Labetalol Hydrochloride NDC 72888-122

Product information

Brand name (proprietary)

Labetalol Hydrochloride

Generic name (nonproprietary)

labetalol hydrochloride

Active ingredients

Labetalol hydrochloride — 300 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Advagen Pharma Ltd

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 211953

Marketing start

Aug 18, 2021

Listing expires

Dec 31, 2027

Other FDA classes

Adrenergic beta-Antagonists (Mechanism)

Identifiers

Product ID 72888-122_4e76bf70-d160-7cdd-e063-6294a90a3b7fSPL ID 4e76bf70-d160-7cdd-e063-6294a90a3b7fSPL set ID 1c680447-b43a-4ff1-bc64-2c2174ca1c9aRxCUI 896758, 896762, 896766UNII 1GEV3BAW9JUPC 0372888120010, 0372888120058, 0372888121055, 0372888122014, 0372888122052, 0372888121017

Pharmacologic class

beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472888012201 followed by a unit qualifier and the quantity Copy

Package 72888-0122-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 211953

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.